[straight news network Beijing March 11 hearing (China Pharmaceutical network) recently, in 2016 the medical community discussion the two sessions, NPC deputies and CPPCC National Committee on traditional Chinese medicine active "suggestions": Traditional Chinese medicine research and development to improve the approval mechanism, encourage Chinese medicine enterprises go out of the country, enhance the competitiveness of China's pharmaceutical industry.

Deputies to the National People's Congress, Yabao pharmaceutical chairman Renwu Xian told Xinhua reporters said that Chinese medicine is treasure of the Chinese nation. It plays an important role of old people, the review of research and development system of Chinese medicine should be in accordance with the standards of Chinese medicine should be used in accordance with the thousands of years of traditional pharmacy to develop in line with the traditional Chinese medicine research. Medical evaluation, hope to speed up the reform of the State Food and drug administration, the implementing regulations of drug evaluation, promote the quality of drugs. From the supply side reform perspective, the supply side is to create a market, the enterprise must innovate, should go abroad to supply all over the world, enhance the world competitiveness of China's pharmaceutical industry.

"In drug research and development, there is still no a complete, suitable for China's national conditions of a traditional Chinese medicine research and development and approval of the mechanism, basically still use of chemical medicine method. These methods have a lot of R & D is not suitable for traditional Chinese medicine, need carries the reform in these areas to improve, so as to further promote the development of traditional Chinese medicine." Ren Wuxian said.

A good start this year, "13th Five-Year" the first year, a good step, crucial. Pharmaceutical industry as a strategic emerging industries by the party and the state attaches great importance to, the first working day lunar new year, the State Council held executive meeting, the medicine to promote the upgrading of industrial innovation, better Fuku Megumio, steady growth. The State Council's first executive meeting focused on pharmaceutical and health industry, which shows that the health industry has gained national attention, but also means that the development of the pharmaceutical industry, faced with unprecedented opportunities. During 12th Five-Year, the pharmaceutical industry stable and healthy development.

The State Council recently issued the "outline of the strategic planning of the development of traditional Chinese medicine (20162030 years)". "Outline" clearly the next fifteen years the development direction of Chinese medicine and the focus of the work, is to promote the development of China's traditional Chinese medicine in the new era of programmatic document. Deputies to the National People's Congress, sunflower pharmaceutical chairman Guan Yanbin told Xinhua reporters, said the plan mentioned something to the floor, at the national policy level, should encourage and support Chinese medicine industry leading enterprises through mergers and acquisitions, equity participation, to enhance the industry's concentration degree.

Reporters learned that the Chinese go out also face many difficulties. Guan Yanbin said that at present we Chinese medicine industry also shows the characteristics of small scale, production enterprises, product quality is also uneven dispersion. Chinese medicine to go out is a lengthy process, only give preferential policies to mergers and acquisitions to enhance industry concentration, encourage support Chinese herbal medicine enterprises to go abroad to participate in the world competition, can make traditional Chinese medicine level can promote quickly catch up with and surpass the advanced world levels.

Meeting, many on behalf of members on the internationalization of traditional Chinese medicine (TCM) launched a heated discussion, how to realize the internationalization of traditional Chinese medicine in China has also become the focus of NPC deputies and CPPCC members of the hot, a member of the CPPCC National Committee, Tianjin Darentang Jingwanhong Pharmaceutical General Manager James said that in the treatment of chronic and difficult to heal wounds, external use traditional Chinese medicine with western medicine can not match advantage. This is a good starting point. Compared with the oral preparation medicine of Chinese traditional medicine is more easy to observe less interference factors, curative effect and exact, and traditional Chinese medicine enterprise in our country should breakthrough in the field of traditional Chinese medicine for external use, thus leading to the process of internationalization of Chinese medicine.

Interpretation of the news hot spots, showing sensitive events, more exclusive analysis, in the "things" WeChat, scan two-dimensional code free reading.